Press Releases

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn’s Proprietary Gene Traffic Control® Platform

Foghorn Therapeutics 12.13.2021

Flagship Pioneering Launches Harbinger Health to Detect Early Cancer with a Simple, Bio-AI Based Blood Test

12.07.2021

Generate Biomedicines Announces First External Equity Raise of $370 Million to Advance its Drug Generation Platform

Generate Biomedicines 11.18.2021

Flagship Pioneering Launches Alltrna to Unlock Transfer RNA Biology and Treat Thousands of Diseases with a Single tRNA Medicine

11.09.2021

Pioneering Medicines, an Initiative of Flagship Pioneering, Establishes First-of-its-Kind Partnership with Cystic Fibrosis Foundation to Develop Breakthrough Treatments for CF

11.03.2021

Laronde Attracts $440M in First External Financing to Further Advance Endless™ RNA Platform

Laronde 08.30.2021

Dr. Stephen Hahn, 24th U.S. FDA Commissioner and former Chief Medical Executive at MD Anderson, joins Flagship Pioneering as Chief Medical Officer of its Preemptive Medicine and Health Security Initiative

06.14.2021

Flagship Pioneering Closes $3.4 Billion Capital Pool to Drive Continued Breakthrough Innovations in Human Health and Sustainability

06.14.2021

Flagship Pioneering Unveils Laronde to Advance Endless RNA™ - A New Class of Programmable Medicines Capable of Expressing Therapeutic Proteins Inside the Body

Laronde 05.10.2021

Flagship Pioneering Expands Biotech Footprint to Property in Somerville’s Boynton Yards

Tessera Therapeutics, Cellarity 03.31.2021

Loading